Karyopharm Therapeutics Inc (KPTI) Insider Trading
- $10,245,912.22
- $142,165,901.96
- Oct. 4, 2024
- Ltd Chione
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 7, 2017 | SVP | 4,958 | $11.25 | Sell | $55,777.50 | |
| Oct. 2, 2017 | Director | 2,000 | $12.00 | Sell | $24,000.00 | |
| Oct. 2, 2017 | SVP | 1,500 | $12.00 | Sell | $18,000.00 | |
| Sept. 15, 2017 | Director | 2,882 | $11.00 | Sell | $31,702.00 | |
| Sept. 15, 2017 | SVP | 2,000 | $11.00 | Sell | $22,000.00 | |
| Sept. 11, 2017 | Director | 118 | $11.00 | Sell | $1,298.00 | |
| Aug. 29, 2017 | SVP | 2,195 | $10.00 | Sell | $21,950.00 | |
| June 26, 2017 | SVP | 805 | $10.03 | Sell | $8,074.15 | |
| Nov. 14, 2016 | Insider | 3,309 | $10.06 | Sell | $33,288.54 | |
| June 23, 2016 | Major Shareholder | 18,824 | $8.03 | Sell | $151,156.72 | |
| June 13, 2016 | Major Shareholder | 7,074 | $8.51 | Sell | $60,199.74 | |
| June 9, 2016 | Major Shareholder | 45,541 | $9.21 | Sell | $419,432.61 | |
| June 7, 2016 | Major Shareholder | 40,000 | $9.24 | Sell | $369,600.00 | |
| June 2, 2016 | Major Shareholder | 17,855 | $9.65 | Sell | $172,300.75 | |
| June 1, 2016 | Major Shareholder | 74,664 | $9.61 | Sell | $717,521.04 | |
| May 31, 2016 | Major Shareholder | 17,096 | $9.66 | Sell | $165,147.36 | |
| May 27, 2016 | Major Shareholder | 40,000 | $9.58 | Sell | $383,200.00 | |
| May 26, 2016 | Major Shareholder | 46,122 | $9.73 | Sell | $448,767.06 | |
| May 23, 2016 | Major Shareholder | 93,932 | $8.54 | Sell | $802,179.28 | |
| May 18, 2016 | Major Shareholder | 63,800 | $8.15 | Sell | $519,970.00 | |
| May 16, 2016 | Major Shareholder | 10,400 | $8.01 | Sell | $83,304.00 | |
| May 11, 2016 | Major Shareholder | 31,868 | $8.24 | Sell | $262,592.32 | |
| Dec. 8, 2015 | Director | 15,000 | $15.01 | Sell | $225,150.00 | |
| April 7, 2015 | EVP | 3,000 | $31.81 | Buy | $95,430.00 | |
| April 2, 2015 | Director | 3,000 | $29.31 | Buy | $87,930.00 | |
| April 2, 2015 | CFO | 5,000 | $29.71 | Buy | $148,550.00 | |
| Jan. 12, 2015 | Insider | 25,000 | $33.00 | Sell | $825,000.00 | |
| Jan. 12, 2015 | CEO | 50,000 | $33.00 | Sell | $1,650,000.00 | |
| Jan. 12, 2015 | Director | 45,454 | $33.00 | Buy | $1,499,982.00 | |
| Dec. 2, 2014 | Director | 10,000 | $43.52 | Sell | $435,200.00 | |
| Dec. 1, 2014 | Major Shareholder | 278,115 | $41.92 | Sell | $11,658,580.80 | |
| Nov. 25, 2014 | Major Shareholder | 242,800 | $42.40 | Sell | $10,294,720.00 | |
| Nov. 19, 2014 | Major Shareholder | 65,968 | $40.09 | Sell | $2,644,657.12 | |
| Nov. 12, 2014 | Major Shareholder | 164,100 | $42.83 | Sell | $7,028,403.00 | |
| Nov. 11, 2014 | Major Shareholder | 54,100 | $42.51 | Sell | $2,299,791.00 | |
| Nov. 10, 2014 | Director | 5,000 | $45.05 | Sell | $225,250.00 | |
| Nov. 10, 2014 | Major Shareholder | 65,000 | $43.40 | Sell | $2,821,000.00 | |
| Nov. 6, 2014 | Major Shareholder | 272,784 | $42.11 | Sell | $11,486,934.24 | |
| Oct. 29, 2014 | Director | 3,500 | $40.05 | Sell | $140,175.00 | |
| Sept. 26, 2014 | Major Shareholder | 50,000 | $42.54 | Sell | $2,127,000.00 | |
| Sept. 24, 2014 | Major Shareholder | 22,498 | $40.32 | Sell | $907,119.36 | |
| Sept. 18, 2014 | Major Shareholder | 12,347 | $40.24 | Sell | $496,843.28 | |
| Sept. 17, 2014 | Major Shareholder | 9,569 | $40.26 | Sell | $385,247.94 | |
| Sept. 12, 2014 | Major Shareholder | 4,312 | $41.12 | Sell | $177,309.44 | |
| Sept. 8, 2014 | Major Shareholder | 35,666 | $39.92 | Sell | $1,423,786.72 | |
| Sept. 4, 2014 | Major Shareholder | 12,795 | $38.07 | Sell | $487,105.65 | |
| Aug. 27, 2014 | Major Shareholder | 43,699 | $38.80 | Sell | $1,695,521.20 | |
| Aug. 25, 2014 | Major Shareholder | 4,389 | $38.08 | Sell | $167,133.12 | |
| Aug. 15, 2014 | Major Shareholder | 8,027 | $39.11 | Sell | $313,935.97 | |
| Aug. 11, 2014 | Major Shareholder | 36,979 | $37.30 | Sell | $1,379,316.70 |
Insiders are both buying and selling Karyopharm Therapeutics Inc stock.
The insider traders at Karyopharm Therapeutics Inc are: Ltd Chione, Michael Kauffman, Sharon Shacham, Richard A Paulson, Christopher Brett Primiano, Mansoor Raza Mirza, Marcin Czernik, Michael Mason, Deepika Pakianathan, Jatin Shah, Stuart Poulton, Sohanya Roshan Cheng, Reshma Rangwala, Ran Frenkel, Garen G Bohlin, Stephen Mitchener, Michael Mano, Tanya Lewis, John Demaree, Justin A Renz, Ltd Plio, Paul Brannelly, Paulson Richard A., and Barry E Greene
The most active insider trader at Karyopharm Therapeutics Inc is Ltd Chione with 36 trades.
Ltd Chione has sold the most Karyopharm Therapeutics Inc stock with a total value of $91,689,798.39.
Deepika Pakianathan has bought the most Karyopharm Therapeutics Inc stock with a total value of $10,995,453.42.
The most recent insider trade for Karyopharm Therapeutics Inc was on Oct. 4, 2024.
The single biggest insider buy for Karyopharm Therapeutics Inc was from Deepika Pakianathan with a total value of $5,000,000.00 on Nov. 12, 2013.
The single biggest insider sell for Karyopharm Therapeutics Inc was from Ltd Plio with a total value of $17,770,000.00 on July 23, 2014.